glp-1 prior authorization criteria MCT2D obesitymedicine #medicare #glp1 #patientaccess #priorauthorization

doi: 10.3389/fnut.2026.1778794 Received 31 December 2025 Revised 12 February 2026 Accepted 17 March 2026 Published 31 March 2026 Volume 13 - 2026 Edited by Zhenwei Wang, The First Affiliated Hospital of Zhengzhou University, China Reviewed by Saba Miri, Humber College, Canada Guorui Zhao, Peking University Sixth Hospital, China Updates Copyright 2026 Dhieb and Bastaki

We also know that adherence to GLP-1s can be challenging due to their adverse effect profile

I recommend trying to get a appointment first thing in the AM

Your doctor can design a tapering protocol based on your current dose and timeline

A growing body of research and experts have suggested that GLP-1s can be powerful tools for midlife women